• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement.

    NYTIMES

    NHS England scraps 7 more drugs on prescription

    PHARMATIMES

    Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS

    FIERCE PHARMA

    Accidental court filing reveals Novartis` kickback settlement talks

    FIERCE PHARMA

    Par Pharma`s Generic Aliskiren Hemifumarate; Hydrochlorothiazide Receives Tentative Approval in US

    FDA

    Aliskiren product-specific bioequivalence guidance

    EMA

    Noden Pharma DAC`s Rasilez HCT (aliskiren / hydrochlorothiazide) Approval in EU

    EMA

    Sales reps, doctors to testify in Novartis kickbacks case

    FIERCEPHARMA

    Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets

    BIOSPACE

    Noden Pharma Notified of ANDA Filing for Tekturna®

    PR NEWSWIRE

    New FDA Report Cites 22 Drugs That Passed PhII But Crashed and Burned in PhIII

    BIOSPACE

    Novartis refused patent for anti-hypertension drug combination

    FINANCIAL EXPRESS

    APAC Anti-hypertensive Therapy Market Hit $15.7 Billion in 2014

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.